Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03613532
Title Venetoclax Added to Fludarabine + Busulfan Prior to Transplant for AML, MDS, and MDS/MPN
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Jacqueline Garcia, MD
Indications

acute myeloid leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia

myelodysplastic/myeloproliferative neoplasm

Therapies

Busulfan + Fludarabine + Venetoclax

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST